Meet-The-Expert Sessions

Saturday 13 April 2019

8:45-9:45, Hall G
How to deal with antimicrobial drug and vaccine shortages?
co-organised with ESCMID Study Groups ESGAP and EVASG

Guillaume Beraud (Canada)
Larissa May (United States)

8:45-9:45, Hall L
How to manage and treat Crimean-Congo and other haemorrhagic fevers
co-organised with the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD)

Nurcan Baykam (Turkey)
Marta Mora-Rillo (Spain)

Sunday 14 April 2019

7:30-8:30, Hall F
Changing my laboratory: drivers and critical parameters of the process

Suzan D. Pas (Netherlands)
François Vandenesch (France)

7:30-8:30,Hall N
Making sense of genome shreds: tools and strategies for straightforward genome data analysis
co-organised with the ESCMID Study Groups ESGEM and ESGMD

David Aanensen (United Kingdom)
Natacha Couto (Netherlands)

7:30-8:30, Hall E
Decision-making in the detection and management of patients with sepsis and critical illness in resource-limited settings

Mervyn Mer (South Africa)
Heiman Wertheim (Netherlands)

7:30-8:30, Hall D
How to treat diabetic foot infections in view of new guidance?
co-organised with the Turkish Society of Clinical Microbiology and Infectious Diseases (KLIMIK)

Mustafa B. Ertuğrul (Turkey)
Ilker Uçkay (Switzerland)

7:30-8:30, Hall G
Difficult treatment scenarios in transplant patients with opportunistic viral infections: a case-based approach

Nina Khanna (Switzerland)
Roy Chemaly (United States)

Monday 15 April 2019

7:30-8:30, Hall B
What I think should be the standard in diagnosing human mycoplasma infections
co-organised with the ESCMID Study Group ESGMAC

Cecile Bebear (France)
Jonas M. Winchell (United States)

7:30-8:30, Hall N
How to study, test and modulate microbiota before transfer/transplantation?
co-organised with ESCMID Study Groups ESGMD and ESGHAMI

Benjamin Davido (France)
Elisabeth Terveer (Netherlands)

7:30-8:30, Hall C
Difficulties to diagnose invasive fungal infection in paediatric patients
co-organised with the ESCMID Study Group EFISG

Elio Castagnola (Italy)
Thomas Lehrnbecher (Germany)

7:30-8:30, Hall E
EUCAST frequently asked questions
co-organised with the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Rafael Canton Moreno (Spain)
Erika Matuschek (Sweden)

7:30-8:30, Hall K
The Endocarditis Team: let's make it work!
co-organised with ESCMID Study Group ESGBIES

Susan Rehm (United States)
Siegbert Rieg (Germany)

7:30-8:30, Hall C
How to manage orthopaedic implant infection? Real-life clinical case discussion
co-organised with the ESCMID Study Group ESGIAI

Martin McNally (United Kingdom)
Marjan Wouthuyzen-Bakker (Netherlands)

7:30-8:30, Hall J
How to use Point-of-Care tests in microbiology: European versus USA experiences

Robin Patel (United States)
Maurizio Sanguinetti (Italy)

7:30-8:30, Hall G
How and when should PCR be used in the diagnosis of C. difficile infection?
co-organised with the ESCMID Study Group ESGCD

Ferric C. Fang (United States)
Maja Rupnik (Slovenia)

7:30-8:30, Hall D
How to implement effective antimicrobial stewardship measures in the era of MDR and XDR pathogens
co-organised with the Hellenic Society for Chemotherapy

Ana Gales (Brazil)
Maddalena Giannella (Italy)

Tuesday 16 April 2019

7:30-8:30, Hall M
Which host response assays are ready to get implemented in clinical practice?

Giovanni Delogu (Italy)
TBA

7:30-8:30, Hall C
What is needed for paving the way to HCV elimination?
co-organised with the European Association for the Study of the Liver (EASL)

Markus Cornberg (Germany)
Jean-Michel Pawlotsky (France

7:30-8:30, Hall J
Burning questions concerning the antimicrobial therapy of sepsis
co-organised with ESCMID Study Groups ESGAP and ESGBIES

Johan Mouton (Netherlands)
David L. Paterson (Australia)

7:30-8:30, Hall F
How to define fungal infection in critically ill patients: new ESCMID guidance?
co-organised with ESCMID Study Groups ESGCIP and EFISG

Matteo Bassetti (Italy)
Cornelia Lass-Flörl (Austria)

7:30-8:30, Hall G
How I manage vascular graft infection
co-organised with the ESCMID Study Group ESGIAI

Efthymia Giannitsioti (Greece)
Eric Senneville (France)

7:30-8:30, Hall D
How to implement and use metagenomics in infectious disease diagnostics and management?
co-organised with the Turkish Society of Clinical Microbiology

Koray Ergunay (Turkey)
Justin O'Grady (United Kingdom)

7:30-8:30, Hall B
How to best manage difficult-to-treat infectious diseases in migrants
co-organised with ESCMID Study Group ESGITM and the Infectious Diseases and Clinical Microbiology Specialty Society of Turkey (EKMUD)

Susanna Capone (Italy)
Christian Wejse (Australia)

7:30-8:30, Hall E
How to manage immunocompromised patients with central nervous system infection?
co-organised with ESCMID Study Groups ESGBIES and ESGICH

Paola Cinque (Italy)
Oriol Manuel (Switzerland)